Oragenics, Inc. to Present Data on Its Peptide Synthesis Platform at the American Peptide Symposium June 25, 2019
Recent Peer-Reviewed Publication on Oragenics, Inc.’s Lantibiotic Antimicrobial Compound Identifies Alternative Mechanism of Action June 17, 2019
Newly Published Preclinical Data on Oragenics, Inc.’s Lantibiotic Compound Demonstrates Tolerability and Compartmentalization to the GI Tract May 13, 2019
Oragenics, Inc. Enters into Collaboration with Florida International University to Expand Its Pipeline of Lantibiotics March 27, 2019
